Medicamen Biotech Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Medicamen Biotech Limited has informed the stock exchanges that it has received a certificate under SEBI’s Depositories and Participants Regulations, 2018. This regulatory document confirms that the company’s shares are eligible for dematerialization and settlement through the depository system.

For investors, this development is a procedural milestone that ensures the stock can be traded smoothly in electronic form. It signifies the company’s compliance with market standards, which is a routine but necessary step for maintaining a healthy listing on the exchange.

Investors should monitor the company’s future announcements for any other corporate actions or updates. As this is a standard regulatory filing, it does not immediately impact the stock's price or financial performance, but it reinforces the company's adherence to listing norms.